A Deep-Red-Absorbing Osmium(II)-Based Photosensitizer Evokes Pyroptosis by Targeting Glutamine Metabolism and
Yiyi Zhang1, Zhimei Xiao1, James W Southwell1
1Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, 75005 Paris, France.
Abstract:
Pyroptosis plays an emerging role in cancer immunotherapy, however, most currently known compounds that activate this cell death mechanism were discovered serendipitously. Here, we report a pyroptosis-inducing strategy that works through metabolic reprogramming of cancer cells to enhance antitumor immunity. Specifically, an osmium-based photosensitizer (Os) was covalently attached to a small-molecule glutamine carrier protein inhibitor (IMD-0354), to construct the conjugate Os-IMD. This conjugate significantly enhanced the photosensitizer's uptake into cancer cells via the glutamine metabolic pathway, inhibited glutamine uptake, and promoted mitochondrial targeting. As a result, upon light irradiation, Os-IMD induced mitochondrial damage and impaired electron transport chain function as well as intracellular redox homeostasis, leading to a switch in the mode of cell death from the apoptosis typically observed with Os to gasdermin D (GSDMD)-mediated pyroptosis. Our study offers a new avenue for the development of scalable pyroptosis-inducing agents.
Insights
Researchers developed a new strategy to induce pyroptosis, a form of programmed cell death, in cancer cells. This method reprograms cancer cell metabolism, enhancing antitumor immunity and offering a new approach for cancer immunotherapy.
Area of Science:
- Biochemistry
- Immunology
- Materials Science
Background:
- Pyroptosis is an emerging target in cancer immunotherapy.
- Current pyroptosis-inducing compounds are often discovered serendipitously.
Purpose of the Study:
- To develop a novel pyroptosis-inducing strategy via metabolic reprogramming.
- To enhance antitumor immunity using a targeted approach.
Main Methods:
- Constructed an osmium-based photosensitizer-inhibitor conjugate (Os-IMD).
- Utilized a glutamine carrier protein inhibitor (IMD-0354) for targeted delivery.
- Investigated the effects of Os-IMD on cancer cell metabolism and cell death pathways.
Main Results:
- Os-IMD enhanced photosensitizer uptake via the glutamine metabolic pathway.
- Os-IMD inhibited glutamine uptake and promoted mitochondrial targeting.
- Light irradiation of Os-IMD induced gasdermin D (GSDMD)-mediated pyroptosis, switching from apoptosis.
Conclusions:
- Metabolic reprogramming offers a scalable strategy for pyroptosis induction.
- Os-IMD effectively induces pyroptosis through mitochondrial damage and redox imbalance.
- This approach provides a new avenue for developing pyroptosis-inducing agents for cancer immunotherapy.
Related Concept Videos
Photoreceptors and Visual Pathways
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Sulfur Assimilation


